|
Catheter-based coronary interventions: stents
Citations 531-540 of 991 total displayed.
|
Past content
(since Jan 1999):
|
- Images in Cardiovascular Medicine
Debris Trapped by a Distal Protection Device May Mimic No-Reflow During Percutaneous Coronary Intervention
- Robin P. Choudhury, Italo Porto, and Adrian P. Banning
Circulation 2004;109:803-804, doi:10.1161/01.CIR.0000112127.15636.02
[Full text]
- Articles
Incidence, Mechanism, Predictors, and Long-Term Prognosis of Late Stent Malapposition After Bare-Metal Stent Implantation
- Myeong-Ki Hong, Gary S. Mintz, Cheol Whan Lee, Young-Hak Kim, Seung-Whan Lee, Jong-Min Song, Ki-Hoon Han, Duk-Hyun Kang, Jae-Kwan Song, Jae-Joong Kim, Seong-Wook Park, and Seung-Jung Park
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000116751.88818.10
[Abstract]
- Focused Perspectives
You’ve Come a Long Way, Baby*: Cardiovascular Health and Disease in Women: Problems and Prospects
- Nanette K. Wenger
Circulation 2004;109:558-560, doi:10.1161/01.CIR.0000117292.19349.D0
[Full text]
- Clinical Investigations and Reports
Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis
- David R. Holmes, Jr, Martin B. Leon, Jeffrey W. Moses, Jeffrey J. Popma, Donald Cutlip, Peter J. Fitzgerald, Charles Brown, Tim Fischell, Shing Chiu Wong, Mark Midei, David Snead, and Richard E. Kuntz
Circulation 2004;109:634-640, doi:10.1161/01.CIR.0000112572.57794.22
[Abstract]
[Full text]
- Clinical Investigations and Reports
High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary Intervention
- Nobuyuki Takamori, Hiroyuki Azuma, Midori Kato, Shunji Hashizume, Ken-ichi Aihara, Masashi Akaike, Katsuya Tamura, and Toshio Matsumoto
Circulation 2004;109:481-486; published online before print as doi:10.1161/01.CIR.0000109695.39671.37
[Abstract]
[Full text]
- Clinical Investigations and Reports
Inhibition of Restenosis With a Paclitaxel-Eluting, Polymer-Free Coronary Stent: The European evaLUation of pacliTaxel Eluting Stent (ELUTES) Trial
- Anthony Gershlick, Ivan De Scheerder, Bernard Chevalier, Amanda Stephens-Lloyd, Edoardo Camenzind, Christian Vrints, Nicolaus Reifart, Luc Missault, Jean-Jacques Goy, Jeffrey A. Brinker, Albert E. Raizner, Philip Urban, and Alan W. Heldman
Circulation 2004;109:487-493; published online before print as doi:10.1161/01.CIR.0000109694.58299.A0
[Abstract]
[Full text]
- Articles
Volumetric Analysis of In-Stent Intimal Hyperplasia in Diabetic Patients Treated With or Without Abciximab. Results of the Diabetes Abciximab steNT Evaluation (DANTE) Randomized Trial
- Áurea J. Chaves, Amanda G.M.R. Sousa, Luiz A. Mattos, Alexandre Abizaid, Rodolfo Staico, Fausto Feres, Marinella Centemero, Luiz F. Tanajura, Andrea Abizaid, Ibraim Pinto, Galo Maldonado, Ana Seixas, Marco A. Costa, Ângela Paes, Gary S. Mintz, and J. Eduardo Sousa
Circulation published February 2, 2004, doi:10.1161/01.CIR.0000116752.12261.D4
[Abstract]
- Articles
Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients
- Nick E.J. West, Peter N. Ruygrok, Clemens M.C. Disco, Mark W.I. Webster, Wietze K. Lindeboom, William W. O’Neill, Nestor F. Mercado, and Patrick W. Serruys
Circulation published February 2, 2004, doi:10.1161/01.CIR.0000116750.63158.94
[Abstract]
- Articles
Implications of Upstream Glycoprotein IIb/IIIa Inhibition and Coronary Artery Stenting in the Invasive Management of Unstable Angina/Non-ST-Elevation Myocardial Infarction. A Comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB Trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 Trial
- Marc S. Sabatine, David A. Morrow, Robert P. Giugliano, Sabina A. Murphy, Laura A. Demopoulos, Peter M. DiBattiste, William S. Weintraub, Carolyn H. McCabe, Elliott M. Antman, Christopher P. Cannon, and Eugene Braunwald
Circulation published February 2, 2004, doi:10.1161/01.CIR.0000112604.74713.35
[Abstract]
- Correspondence
Drug-Eluting Stents: Do We Know Enough About Safety?
- Jürgen R. Sindermann, Gabriele Plenz, and Günter Breithardt
Circulation 2004;109:e22, doi:10.1161/01.CIR.0000113712.96752.F8
[Full text]
|
|
